Delving Deeper into Genotypic-Phenotypic Associations in Idiopathic Pulmonary Fibrosis. [PDF]
Montesi SB, Adegunsoye A.
europepmc +1 more source
SESN3 restrains the progress of idiopathic pulmonary fibrosis by targeting the activity of FOSL2. [PDF]
Sun Y, Chen D, Liu F, Liu T.
europepmc +1 more source
A Twist in the Fibrotic Tale: The Overlooked Vasculopathy in Idiopathic Pulmonary Fibrosis. [PDF]
Tonelli AR, Sahay S.
europepmc +1 more source
Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study. [PDF]
Lalla F +5 more
europepmc +1 more source
Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis. [PDF]
Cabrera-César E +12 more
europepmc +1 more source
Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target. [PDF]
Kim S +13 more
europepmc +1 more source
Geriatric nutrition risk index as an indicator of acute exacerbation and mortality risk in patients with idiopathic pulmonary fibrosis. [PDF]
Pınar Deniz P +3 more
europepmc +1 more source
Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry. [PDF]
Fahim A +14 more
europepmc +1 more source

